Showing results (181-190 of 466) with videos related to
Sort By:
Pageof 47
Plos One|May 10, 2013
Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetesNiwanthi W Rajapakse, Abigail L Chong, Wei-Zheng Zhang, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 11, 2013
Reducing iodinated contrast volume by manipulating injection pressure during coronary angiographyDavid M Kaye, Dion Stub, Vivian Mak, et al.Journal of the American College of Cardiology|November 16, 2004
Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotypeDavid M Kaye, Belinda Smirk, Samara Finch, et al.Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|August 28, 2018
Subclinical Left Ventricular Dysfunction is Influenced by Genotype Severity in Patients with Cystic FibrosisMichael Pallin, Dominic Keating, David M Kaye, et al.Pharmacogenetics|July 2, 2003
Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failureDavid M Kaye, Belinda Smirk, Carolyn Williams, et al.Journal of Cellular Biochemistry|June 23, 2009
Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injuryKylie M Venardos, Amanda J Zatta, Tanneale Marshall, et al.Heart, Lung & Circulation|February 14, 2022
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical ChallengesFiona Thoi, Daniel J Scherer, David M Kaye, et al.British Journal of Clinical Pharmacology|February 13, 2003
Low-dose atorvastatin therapy does not augment endothelial function in active hypercholesterolaemic malesMelinda M Parnell, Jaye P F Chin-Dusting, Jennifer Starr, et al.Frontiers in Pharmacology|March 7, 2019
CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated CardiomyopathyPo-Yin Chu, Mandar S Joshi, Duncan Horlock, et al.Frontiers in Bioengineering and Biotechnology|November 27, 2024
Computational modelling of valvular heart disease: haemodynamic insights and clinical implicationsMichael Šeman, Andrew F Stephens, David M Kaye, et al.Pageof 47